AKT1 and cancer: Protein overexpression and activation and somatic aberrations of PI3K-Akt pathway genes have been commonly observed in a variety of malignancies, and this pathway has been extensively investigated as one of the critical mechanisms in tumorigenesis and as a target for cancer therapy [7, 9].